European surveillance study on the antibiotic susceptibility of Propionibacterium acnes

C. Oprica, Carl Erik Nord, S. Kalenic, D. Chmelar, B. Lundgren, E. Könönen, M. Rautio, A. Rodloff, E. Bezirtzoglou, E. Nagy, M. G. Menozzi, J. Brazier, H. Endtz, F. Müller, J. Kolman, M. Hedberg, L. Emtestam, B. Lund

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Propionibacterium acnes strains are recovered from infections linked to surgical procedures, foreign bodies and septicaemia. This study investigated the antibiotic susceptibility patterns of P. acnes isolates from different systemic infections and determined the genomic diversity among resistant P. acnes isolates with low-frequency restriction analysis of chromosomal DNA by pulsed-field gel electrophoresis (PFGE). In total, 304 P. acnes isolates from 13 laboratories in 13 European countries were tested against six antimicrobial agents by the NCCLS reference agar dilution method and the breakpoints recommended by the European Committee on Antimicrobial Susceptibility Testing. Blood isolates were encountered most frequently, followed by those from skin and soft tissue infections, and abdominal infections. Of the isolates examined, 2.6% were resistant to tetracycline, 15.1% to clindamycin, and 17.1% to erythromycin. No resistance was observed to linezolid, benzylpenicillin or vancomycin. There was considerable variation between countries in the proportion of resistant strains, ranging from 83% in Croatia and 60% in Italy to 0% in The Netherlands. Isolates from blood were predominant among the resistant isolates. Seventeen clones and 78 banding patterns were identified among the resistant isolates. It was concluded that antimicrobial resistance has now emerged among P. acnes isolates from systemic infections.

Original languageEnglish
Pages (from-to)204-213
Number of pages10
JournalClinical Microbiology and Infection
Volume11
Issue number3
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Propionibacterium acnes
Anti-Bacterial Agents
Linezolid
Infection
Soft Tissue Infections
Croatia
Penicillin G
Clindamycin
Pulsed Field Gel Electrophoresis
Erythromycin
Vancomycin
Anti-Infective Agents
Foreign Bodies
Tetracycline
Netherlands
Italy
Agar
Sepsis
Clone Cells
Skin

Keywords

  • Antimicrobial resistance
  • Clinical isolates
  • Propionibacterium acnes
  • Pulsed-field gel electrophoresis
  • Resistance

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Oprica, C., Nord, C. E., Kalenic, S., Chmelar, D., Lundgren, B., Könönen, E., ... Lund, B. (2005). European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clinical Microbiology and Infection, 11(3), 204-213. https://doi.org/10.1111/j.1469-0691.2004.01055.x

European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. / Oprica, C.; Nord, Carl Erik; Kalenic, S.; Chmelar, D.; Lundgren, B.; Könönen, E.; Rautio, M.; Rodloff, A.; Bezirtzoglou, E.; Nagy, E.; Menozzi, M. G.; Brazier, J.; Endtz, H.; Müller, F.; Kolman, J.; Hedberg, M.; Emtestam, L.; Lund, B.

In: Clinical Microbiology and Infection, Vol. 11, No. 3, 01.01.2005, p. 204-213.

Research output: Contribution to journalArticle

Oprica, C, Nord, CE, Kalenic, S, Chmelar, D, Lundgren, B, Könönen, E, Rautio, M, Rodloff, A, Bezirtzoglou, E, Nagy, E, Menozzi, MG, Brazier, J, Endtz, H, Müller, F, Kolman, J, Hedberg, M, Emtestam, L & Lund, B 2005, 'European surveillance study on the antibiotic susceptibility of Propionibacterium acnes', Clinical Microbiology and Infection, vol. 11, no. 3, pp. 204-213. https://doi.org/10.1111/j.1469-0691.2004.01055.x
Oprica, C. ; Nord, Carl Erik ; Kalenic, S. ; Chmelar, D. ; Lundgren, B. ; Könönen, E. ; Rautio, M. ; Rodloff, A. ; Bezirtzoglou, E. ; Nagy, E. ; Menozzi, M. G. ; Brazier, J. ; Endtz, H. ; Müller, F. ; Kolman, J. ; Hedberg, M. ; Emtestam, L. ; Lund, B. / European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. In: Clinical Microbiology and Infection. 2005 ; Vol. 11, No. 3. pp. 204-213.
@article{2bbdb8a053a849e9be15120485b7a1a7,
title = "European surveillance study on the antibiotic susceptibility of Propionibacterium acnes",
abstract = "Propionibacterium acnes strains are recovered from infections linked to surgical procedures, foreign bodies and septicaemia. This study investigated the antibiotic susceptibility patterns of P. acnes isolates from different systemic infections and determined the genomic diversity among resistant P. acnes isolates with low-frequency restriction analysis of chromosomal DNA by pulsed-field gel electrophoresis (PFGE). In total, 304 P. acnes isolates from 13 laboratories in 13 European countries were tested against six antimicrobial agents by the NCCLS reference agar dilution method and the breakpoints recommended by the European Committee on Antimicrobial Susceptibility Testing. Blood isolates were encountered most frequently, followed by those from skin and soft tissue infections, and abdominal infections. Of the isolates examined, 2.6{\%} were resistant to tetracycline, 15.1{\%} to clindamycin, and 17.1{\%} to erythromycin. No resistance was observed to linezolid, benzylpenicillin or vancomycin. There was considerable variation between countries in the proportion of resistant strains, ranging from 83{\%} in Croatia and 60{\%} in Italy to 0{\%} in The Netherlands. Isolates from blood were predominant among the resistant isolates. Seventeen clones and 78 banding patterns were identified among the resistant isolates. It was concluded that antimicrobial resistance has now emerged among P. acnes isolates from systemic infections.",
keywords = "Antimicrobial resistance, Clinical isolates, Propionibacterium acnes, Pulsed-field gel electrophoresis, Resistance",
author = "C. Oprica and Nord, {Carl Erik} and S. Kalenic and D. Chmelar and B. Lundgren and E. K{\"o}n{\"o}nen and M. Rautio and A. Rodloff and E. Bezirtzoglou and E. Nagy and Menozzi, {M. G.} and J. Brazier and H. Endtz and F. M{\"u}ller and J. Kolman and M. Hedberg and L. Emtestam and B. Lund",
year = "2005",
month = "1",
day = "1",
doi = "10.1111/j.1469-0691.2004.01055.x",
language = "English",
volume = "11",
pages = "204--213",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - European surveillance study on the antibiotic susceptibility of Propionibacterium acnes

AU - Oprica, C.

AU - Nord, Carl Erik

AU - Kalenic, S.

AU - Chmelar, D.

AU - Lundgren, B.

AU - Könönen, E.

AU - Rautio, M.

AU - Rodloff, A.

AU - Bezirtzoglou, E.

AU - Nagy, E.

AU - Menozzi, M. G.

AU - Brazier, J.

AU - Endtz, H.

AU - Müller, F.

AU - Kolman, J.

AU - Hedberg, M.

AU - Emtestam, L.

AU - Lund, B.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Propionibacterium acnes strains are recovered from infections linked to surgical procedures, foreign bodies and septicaemia. This study investigated the antibiotic susceptibility patterns of P. acnes isolates from different systemic infections and determined the genomic diversity among resistant P. acnes isolates with low-frequency restriction analysis of chromosomal DNA by pulsed-field gel electrophoresis (PFGE). In total, 304 P. acnes isolates from 13 laboratories in 13 European countries were tested against six antimicrobial agents by the NCCLS reference agar dilution method and the breakpoints recommended by the European Committee on Antimicrobial Susceptibility Testing. Blood isolates were encountered most frequently, followed by those from skin and soft tissue infections, and abdominal infections. Of the isolates examined, 2.6% were resistant to tetracycline, 15.1% to clindamycin, and 17.1% to erythromycin. No resistance was observed to linezolid, benzylpenicillin or vancomycin. There was considerable variation between countries in the proportion of resistant strains, ranging from 83% in Croatia and 60% in Italy to 0% in The Netherlands. Isolates from blood were predominant among the resistant isolates. Seventeen clones and 78 banding patterns were identified among the resistant isolates. It was concluded that antimicrobial resistance has now emerged among P. acnes isolates from systemic infections.

AB - Propionibacterium acnes strains are recovered from infections linked to surgical procedures, foreign bodies and septicaemia. This study investigated the antibiotic susceptibility patterns of P. acnes isolates from different systemic infections and determined the genomic diversity among resistant P. acnes isolates with low-frequency restriction analysis of chromosomal DNA by pulsed-field gel electrophoresis (PFGE). In total, 304 P. acnes isolates from 13 laboratories in 13 European countries were tested against six antimicrobial agents by the NCCLS reference agar dilution method and the breakpoints recommended by the European Committee on Antimicrobial Susceptibility Testing. Blood isolates were encountered most frequently, followed by those from skin and soft tissue infections, and abdominal infections. Of the isolates examined, 2.6% were resistant to tetracycline, 15.1% to clindamycin, and 17.1% to erythromycin. No resistance was observed to linezolid, benzylpenicillin or vancomycin. There was considerable variation between countries in the proportion of resistant strains, ranging from 83% in Croatia and 60% in Italy to 0% in The Netherlands. Isolates from blood were predominant among the resistant isolates. Seventeen clones and 78 banding patterns were identified among the resistant isolates. It was concluded that antimicrobial resistance has now emerged among P. acnes isolates from systemic infections.

KW - Antimicrobial resistance

KW - Clinical isolates

KW - Propionibacterium acnes

KW - Pulsed-field gel electrophoresis

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=20044388703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044388703&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2004.01055.x

DO - 10.1111/j.1469-0691.2004.01055.x

M3 - Article

C2 - 15715718

AN - SCOPUS:20044388703

VL - 11

SP - 204

EP - 213

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 3

ER -